Skip to main content
. 2020 Sep 8;20(5):209. doi: 10.3892/ol.2020.12072

Figure 4.

Figure 4.

Combination treatment inhibits A549/DDP cell-derived subcutaneous ectopic tumor growth. (A) Tumor volume was measured from day 0 to day 20 in each group of mice. (B) Tumor weights of A549/DDP xenografts at day 20 following treatment. (C) A549/DDP cell-derived subcutaneous neoplasms on day 20. (D and E) Expression of Ki-67 was detected by immunohistochemistry. Scale bar in (D)=50 µm. *P<0.05, **P<0.01, ****P<0.0001. DDP, cisplatin.